Search Results - "Prevotat, Anne"

The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management by Delhaes, Laurence, Monchy, Sébastien, Fréalle, Emilie, Hubans, Christine, Salleron, Julia, Leroy, Sylvie, Prevotat, Anne, Wallet, Frédérick, Wallaert, Benoit, Dei-Cas, Eduardo, Sime-Ngando, Telesphore, Chabé, Magali, Viscogliosi, Eric

“…Given the polymicrobial nature of pulmonary infections in patients with cystic fibrosis (CF), it is essential to enhance our knowledge on the composition of…”
Get full text

Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis by Soret, Perrine, Vandenborght, Louise-Eva, Francis, Florence, Coron, Noémie, Enaud, Raphael, Avalos, Marta, Schaeverbeke, Thierry, Berger, Patrick, Fayon, Michael, Thiebaut, Rodolphe, Delhaes, Laurence

“…Lung infections play a critical role in cystic fibrosis (CF) pathogenesis. CF respiratory tract is now considered to be a polymicrobial niche and advances in…”
Get full text

The immediate effects of a single autogenic drainage session on ventilatory mechanics in adult subjects with cystic fibrosis by Wallaert, Elliot, Perez, Thierry, Prevotat, Anne, Reychler, Gregory, Wallaert, Benoit, Le Rouzic, Olivier

“…The aim of this study was to gain insight into the physiological changes occurring in subjects with cystic fibrosis (CF) after autogenic drainage (AD). Changes…”
Get full text

Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis by Tetart, Macha, Wallet, Frederic, Kyheng, Maeva, Leroy, Sylvie, Perez, Thierry, Le Rouzic, Olivier, Wallaert, Benoit, Prevotat, Anne

“…The prevalence of lung isolation in cystic fibrosis (CF) patients has increased, but the impact on lung function is controversial. The aim of this study was to…”
Get full text

Predictors of massive haemoptysis after a first episode of mild-to-moderate haemoptysis in patients with cystic fibrosis by Pavaut, Geoffrey, Kyheng, Maeva, Le Rouzic, Olivier, Perez, Thierry, Wallaert, Benoit, Prevotat, Anne

“…The main cause of death of cystic fibrosis (CF) patients is respiratory disease due to secondary infections, haemoptysis, pneumothorax, and respiratory failure…”
Get full text

Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases by Benhabiles, Hana, Gonzalez-Hilarion, Sara, Amand, Séverine, Bailly, Christine, Prévotat, Anne, Reix, Philippe, Hubert, Dominique, Adriaenssens, Eric, Rebuffat, Sylvie, Tulasne, David, Lejeune, Fabrice

“…About 10% of patients with a genetic disease carry a nonsense mutation causing their pathology. A strategy for correcting nonsense mutations is premature…”
Get full text

Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis by Leroy, Catherine, Spelier, Sacha, Essonghe, Nadège Charlene, Poix, Virginie, Kong, Rebekah, Gizzi, Patrick, Bourban, Claire, Amand, Séverine, Bailly, Christine, Guilbert, Romain, Hannebique, David, Persoons, Philippe, Arhant, Gwenaëlle, Prévotat, Anne, Reix, Philippe, Hubert, Dominique, Gérardin, Michèle, Chamaillard, Mathias, Prevarskaya, Natalia, Rebuffat, Sylvie, Shapovalov, George, Beekman, Jeffrey, Lejeune, Fabrice

“…Nonsense mutations are responsible for around 10% of cases of genetic diseases, including cystic fibrosis. 2,6-diaminopurine (DAP) has recently been shown to…”
Get full text

Virus and cystic fibrosis: Rhinoviruses are associated with exacerbations in adult patients by Goffard, Anne, Lambert, Valérie, Salleron, Julia, Herwegh, Stéphanie, Engelmann, Ilka, Pinel, Claudine, Pin, Isabelle, Perrez, Thierry, Prévotat, Anne, Dewilde, Anny, Delhaes, Laurence

“…Abstract Background Few studies have suggested the potential role of respiratory viruses in cystic fibrosis (CF) exacerbation, but their real impact is…”
Get full text

Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease by Hubert, Dominique, Chiron, Raphaël, Camara, Boubou, Grenet, Dominique, Prévotat, Anne, Bassinet, Laurence, Dominique, Stéphane, Rault, Gilles, Macey, Julie, Honoré, Isabelle, Kanaan, Reem, Leroy, Sylvie, Desmazes Dufeu, Nadine, Burgel, Pierre-Régis

“…Abstract Objective To investigate the short-term adverse events and effectiveness of lumacaftor/ivacaftor combination treatment in adults with cystic fibrosis…”
Get full text

Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study by Coron, Noémie, Pihet, Marc, Fréalle, Emilie, Lemeille, Yolande, Pinel, Claudine, Pelloux, Hervé, Gargala, Gilles, Favennec, Loic, Accoceberry, Isabelle, Durand-Joly, Isabelle, Dalle, Frédéric, Huet, Frédéric, Fanton, Annlyse, Boldron, Amale, Loeuille, Guy-André, Domblides, Philippe, Coltey, Bérengère, Pin, Isabelle, Llerena, Catherine, Troussier, Françoise, Person, Christine, Marguet, Christophe, Wizla, Nathalie, Thumerelle, Caroline, Turck, Dominique, Bui, Stéphanie, Fayon, Michael, Duhamel, Alain, Prévotat, Anne, Wallaert, Benoit, Leroy, Sylvie, Bouchara, Jean-Philippe, Delhaes, Laurence

“…Fungal respiratory colonization of cystic fibrosis (CF) patients emerges as a new concern; however, the heterogeneity of mycological protocols limits…”
Get full text

Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease by Pastré, Jean, Prévotat, Anne, Tardif, Catherine, Langlois, Carole, Duhamel, Alain, Wallaert, Benoit

“…Adult patients with cystic fibrosis (CF) frequently have reduced exercise tolerance, which is multifactorial but mainly due to bronchial obstruction. The aim…”
Get full text

Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease by Burgel, Pierre-Régis, Durieu, Isabelle, Chiron, Raphaël, Ramel, Sophie, Danner-Boucher, Isabelle, Prevotat, Anne, Grenet, Dominique, Marguet, Christophe, Reynaud-Gaubert, Martine, Macey, Julie, Mely, Laurent, Fanton, Annlyse, Quetant, Sébastien, Lemonnier, Lydie, Paillasseur, Jean-Louis, Da Silva, Jennifer, Martin, Clémence

“…Elexacaftor-tezacaftor-ivacaftor is a cystic fibrosis transmembrane conductance regulator modulator combination, developed for cystic fibrosis (CF) patients…”
Get full text

Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis by Sanges, Sébastien, Prévotat, Anne, Fertin, Marie, Terriou, Louis, Lefèvre, Guillaume, Quesnel, Bruno, Hatron, Pierre-Yves, Hachulla, Éric, Copin, Marie-Christine, Launay, David

“…We read with great interest the article by Ballerie et al. [1], which describes the occurrence of pulmonary alveolar proteinosis and fibrosis in a patient with…”
Get full text

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis by Burgel, Pierre-Régis, Munck, Anne, Durieu, Isabelle, Chiron, Raphaël, Mely, Laurent, Prevotat, Anne, Murris-Espin, Marlene, Porzio, Michele, Abely, Michel, Reix, Philippe, Marguet, Christophe, Macey, Julie, Sermet-Gaudelus, Isabelle, Corvol, Harriet, Bui, Stéphanie, Lemonnier, Lydie, Dehillotte, Clémence, Da Silva, Jennifer, Paillasseur, Jean-Louis, Hubert, Dominique

“…Lumacaftor-ivacaftor is a CFTR (cystic fibrosis transmembrane conductance regulator) modulator combination recently approved for patients with cystic fibrosis…”
Get full text

Fertility of women with cystic fibrosis: a French survey by Tournier, Anna, Murris, Marlène, Prevotat, Anne, Fanton, Annlyse, Bettiol, Célia, Parinaud, Jean

“…Research question: Although the impact of cystic fibrosis on male fertility is well known, very few studies have investigated its effect on female fertility…”
Get full text

Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial by Slebos, Dirk-Jan, Shah, Pallav L, Herth, Felix J F, Pison, Christophe, Schumann, Christian, Hübner, Ralf-Harto, Bonta, Peter I, Kessler, Romain, Gesierich, Wolfgang, Darwiche, Kaid, Lamprecht, Bernd, Perez, Thierry, Skowasch, Dirk, Deslee, Gaetan, Marceau, Armelle, Sciurba, Frank C, Gosens, Reinoud, Hartman, Jorine E, Srikanthan, Karthi, Duller, Marina, Valipour, Arschang

“…Targeted lung denervation (TLD) is a bronchoscopic radiofrequency ablation therapy for chronic obstructive pulmonary disease (COPD), which durably disrupts…”
Get full text

Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis by Perisson, Caroline, Destruys, Leila, Grenet, Dominique, Bassinet, Laurence, Derelle, Jocelyne, Sermet-Gaudelus, Isabelle, Thumerelle, Caroline, Prevotat, Anne, Rosner, Vincent, Clement, Annick, Corvol, Harriet

“…Allergic bronchopulmonary aspergillosis (ABPA) is a severe lung disease complication caused by an Aspergillus fumigatus-induced hypersensitivity that affects…”
Get full text

Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study by Rakotoarisoa, Luc, Weiss, Laurence, Lefebvre, François, Porzio, Michele, Renaud-Picard, Benjamin, Ravoninjatovo, Bruno, Abely, Michel, Danner-Boucher, Isabelle, Dubois, Séverine, Troussier, Françoise, Prevotat, Anne, Rault, Gilles, Kessler, Romain, Kessler, Laurence

“…Cystic fibrosis related diabetes (CFRD) is commonly associated with declining lung function and nutritional status. We aimed to evaluate the pulmonary impact…”
Get full text

Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF) by Hebestreit, Helge, Kriemler, Susi, Schindler, Christian, Stein, Lothar, Karila, Chantal, Urquhart, Don S, Orenstein, David M, Lands, Larry C, Schaeff, Jonathan, Eber, Ernst, Radtke, Thomas

“…The long-term effects of vigorous physical activity (PA) on lung function in cystic fibrosis are unclear. To evaluate effects of a 12-month partially…”
Get full text

Long-term computed tomographic changes in cystic fibrosis patients treated with ivacaftor by Chassagnon, Guillaume, Hubert, Dominique, Fajac, Isabelle, Burgel, Pierre-Régis, Revel, Marie-Pierre

“…Cystic fibrosis (CF) patients with gating mutations in the gene coding for the CF transmembrane conductance regulator (CFTR) protein have been the first to…”
Get full text